SG
IMUX icon

StoneX Group’s Immunic IMUX Stock Holding History

StoneX Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,054
Closed -$11K – 1081
2025
Q4 		$11K Buy
+2,054
New +$15K ﹤0.01% 995

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

StoneX Group's IMUX Position: Q1 2026 in Review

StoneX Group sold out of Immunic (IMUX) in Q1 2026, closing a stake of 2,054 shares — an estimated $11K sold.

StoneX Group first reported a position in IMUX in Q4 2025 and held it in 1 quarter. The position peaked at $11K in Q4 2025. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • StoneX Group reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 2,054 Immunic shares in Q1 2026, an estimated $11K.
  • StoneX Group first reported a position in Immunic in Q4 2025 and held it in 1 quarter.
  • StoneX Group's Immunic position peaked at $11K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.